Follow the expert with Kellum. Recently he was placed in the top flight of global critical docs at a key Sepsis Alliance meeting. I find that ignorance when investing can be a costly error. Kellum's decision to take on a dual function role as CMO for the Canadian filter company should be recognized as a potential signal to would be investor types. Please, don't misunderstand me, I consider myself an internet pal with Texchen like most do, what a brilliant mind, and his picture leaves little to be desired. For me though, it is a professional of Kellum's class that gets my motor running from an investor point of view. Why would a global key opinion leader of his ilk leave all advisory roles and take a 2 year leave to join a Canadian filter company if in fact they did not have the goods? Upon further analysis they have several FDA achievments and of course a phase 4 FDA confirmatory trial well under way. From a CTSO standpoint endotoxin removal is quite large as our XL filter is said to make stand alone endotoxin filters obsolete and therefore the Canadian company's advancement only stands to be a huge benefit to us in this 20 billion dollar market. I'm once again excited and find the comment on 'pulling hard' to be both ignorant and extremely telling. Embrace advancement, embrace the KOL's and most of all embrace one another as we journey into tomorrow with knowledge we gain today. GLTA!!
